| Tumor-associated endothelial cells with cytogenetic abnormalities K Hida, Y Hida, DN Amin, AF Flint, D Panigrahy, CC Morton, M Klagsbrun Cancer research 64 (22), 8249-8255, 2004 | 538 | 2004 |
| Tumor endothelial cells accelerate tumor metastasis N Maishi, K Hida Cancer science 108 (10), 1921-1926, 2017 | 287 | 2017 |
| Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors DN Amin, K Hida, DR Bielenberg, M Klagsbrun Cancer research 66 (4), 2173-2180, 2006 | 260 | 2006 |
| Contribution of tumor endothelial cells in cancer progression K Hida, N Maishi, DA Annan, Y Hida International journal of molecular sciences 19 (5), 1272, 2018 | 231 | 2018 |
| Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery G Kibria, H Hatakeyama, N Ohga, K Hida, H Harashima Journal of controlled release 153 (2), 141-148, 2011 | 226 | 2011 |
| BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo Y Suzuki, N Ohga, Y Morishita, K Hida, K Miyazono, T Watabe Journal of cell science 123 (10), 1684-1692, 2010 | 211 | 2010 |
| Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors T Akino, K Hida, Y Hida, K Tsuchiya, D Freedman, C Muraki, N Ohga, ... The American journal of pathology 175 (6), 2657-2667, 2009 | 209 | 2009 |
| A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities K Hida, M Klagsbrun Cancer research 65 (7), 2507-2510, 2005 | 194 | 2005 |
| Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment K Akiyama, N Ohga, Y Hida, T Kawamoto, Y Sadamoto, S Ishikawa, ... The American journal of pathology 180 (3), 1283-1293, 2012 | 177 | 2012 |
| Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high-and low-metastatic tumors N Ohga, S Ishikawa, N Maishi, K Akiyama, Y Hida, T Kawamoto, ... The American journal of pathology 180 (3), 1294-1307, 2012 | 176 | 2012 |
| Understanding tumor endothelial cell abnormalities to develop ideal anti‐angiogenic therapies K Hida, Y Hida, M Shindoh Cancer science 99 (3), 459-466, 2008 | 168 | 2008 |
| Tumor angiogenesis—characteristics of tumor endothelial cells K Hida, N Maishi, C Torii, Y Hida International journal of clinical oncology 21 (2), 206-212, 2016 | 153 | 2016 |
| Isolated tumor endothelial cells maintain specific character during long-term culture K Matsuda, N Ohga, Y Hida, C Muraki, K Tsuchiya, T Kurosu, T Akino, ... Biochemical and biophysical research communications 394 (4), 947-954, 2010 | 143 | 2010 |
| HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium T Kurosu, N Ohga, Y Hida, N Maishi, K Akiyama, W Kakuguchi, ... British journal of cancer 104 (5), 819-829, 2011 | 131 | 2011 |
| Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan N Maishi, Y Ohba, K Akiyama, N Ohga, J Hamada, H Nagao-Kitamoto, ... Scientific reports 6 (1), 28039, 2016 | 126 | 2016 |
| RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system Y Sakurai, H Hatakeyama, Y Sato, M Hyodo, H Akita, N Ohga, K Hida, ... Journal of controlled release 173, 110-118, 2014 | 125 | 2014 |
| Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy K Takara, H Hatakeyama, G Kibria, N Ohga, K Hida, H Harashima Journal of Controlled Release 162 (1), 225-232, 2012 | 121 | 2012 |
| Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis T Kawamoto, N Ohga, K Akiyama, N Hirata, S Kitahara, N Maishi, ... PLoS One 7 (3), e34045, 2012 | 117 | 2012 |
| Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes M Hanzawa, M Shindoh, F Higashino, M Yasuda, N Inoue, K Hida, M Ono, ... Carcinogenesis 21 (6), 1079-1085, 2000 | 117 | 2000 |
| Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells K Yamamoto, N Ohga, Y Hida, N Maishi, T Kawamoto, K Kitayama, ... British journal of cancer 106 (6), 1214-1223, 2012 | 112 | 2012 |
Masanobu ShindohProfessorVerified email at den.hokudai.ac.jp
